Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DOCS 
Doximity Inc (DOCS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: DOCS (4-star) is a SELL. SELL since 4 days. Simulated Profits (8.61%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
19 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $70.72
1 Year Target Price $70.72
| 5 | Strong Buy |
| 3 | Buy |
| 11 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 5.61% | Avg. Invested days 42 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.61B USD | Price to earnings Ratio 57.55 | 1Y Target Price 70.72 |
Price to earnings Ratio 57.55 | 1Y Target Price 70.72 | ||
Volume (30-day avg) 19 | Beta 1.38 | 52 Weeks Range 40.87 - 85.21 | Updated Date 10/17/2025 |
52 Weeks Range 40.87 - 85.21 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 39.88% | Operating Margin (TTM) 37.48% |
Management Effectiveness
Return on Assets (TTM) 13.13% | Return on Equity (TTM) 24.25% |
Valuation
Trailing PE 57.55 | Forward PE 47.62 | Enterprise Value 12654556052 | Price to Sales(TTM) 21.39 |
Enterprise Value 12654556052 | Price to Sales(TTM) 21.39 | ||
Enterprise Value to Revenue 21.46 | Enterprise Value to EBITDA 50.73 | Shares Outstanding 136400248 | Shares Floating 133218613 |
Shares Outstanding 136400248 | Shares Floating 133218613 | ||
Percent Insiders 2.29 | Percent Institutions 91.42 |
Upturn AI SWOT
Doximity Inc
Company Overview
History and Background
Doximity was founded in 2010. It's a professional network for U.S. physicians and other healthcare professionals. It facilitates communication, collaboration, and knowledge sharing within the medical community. It went public in 2021.
Core Business Areas
- Marketing Solutions: Allows pharmaceutical manufacturers and healthcare systems to reach and engage with physicians through targeted advertising and sponsored content.
- Hiring Solutions: Connects healthcare organizations with qualified physicians and other healthcare professionals seeking employment opportunities.
- Telehealth Solutions: Offers a telehealth platform integrated into the Doximity network, enabling physicians to conduct virtual patient consultations.
Leadership and Structure
The CEO is Jeff Tangney. The company has a typical corporate structure with departments covering technology, sales, marketing, finance, and operations. The board of directors provides oversight.
Top Products and Market Share
Key Offerings
- Doximity Dialer: A secure mobile app that allows physicians to call patients from their mobile phones while displaying their clinic's number. No definitive market share data available. Competitors include Updox and Klara.
- Doximity Talent Finder: A hiring platform that connects healthcare organizations with physicians. Revenue is generated through subscription fees. No definitive market share data available. Competitors include LinkedIn Recruiter and Indeed.
- Doximity Marketing Solutions: Allows pharmaceutical companies to advertise to physicians. Doximity is a key player in pharma marketing to physicians. No exact market share data available but it's considered a large portion of their revenue. Competitors include traditional medical journals, online medical news sites, and other targeted advertising platforms.
Market Dynamics
Industry Overview
The healthcare communications and marketing industry is experiencing growth driven by digital transformation and the increasing need for targeted outreach to healthcare professionals.
Positioning
Doximity is uniquely positioned as a leading professional network for physicians, offering a concentrated and engaged audience for pharmaceutical companies and healthcare organizations.
Total Addressable Market (TAM)
Estimated TAM for pharmaceutical marketing and physician recruitment in the US is in the billions. Doximity has a substantial share but significant room to grow.
Upturn SWOT Analysis
Strengths
- Large and engaged physician network
- Strong brand recognition within the medical community
- Data-driven marketing solutions
- Recurring revenue model
Weaknesses
- Reliance on the U.S. physician market
- Potential saturation of marketing solutions
- Dependence on third-party data for user verification
Opportunities
- Expansion into international markets
- Development of new telehealth and communication tools
- Partnerships with healthcare technology companies
- Further penetration into other healthcare professional segments (e.g., nurses, pharmacists)
Threats
- Increased competition from other professional networks
- Changes in healthcare regulations
- Data privacy concerns
- Economic downturn affecting pharmaceutical marketing budgets
Competitors and Market Share
Key Competitors
- MDGL
- MMS
- SVGN
Competitive Landscape
Doximity's main advantage lies in its large and engaged physician network. Competitors may offer more specialized solutions or lower prices.
Major Acquisitions
Ambra Health
- Year: 2022
- Acquisition Price (USD millions): 54
- Strategic Rationale: To expand Doximity's offerings into medical image management and telehealth services.
Growth Trajectory and Initiatives
Historical Growth: Doximity has experienced rapid growth in revenue and user base since its founding.
Future Projections: Analysts project continued growth in revenue and earnings, driven by increased adoption of its marketing and hiring solutions.
Recent Initiatives: Recent initiatives include expanding its telehealth capabilities, launching new marketing products, and investing in AI-powered tools.
Summary
Doximity is a strong company with a valuable physician network, strong marketing solutions and growing telehealth platform. Its primary risk is increased competition and changes in healthcare regulations. Doximity is experiencing steady growth and improving profit margins, driven by its core marketing and hiring solutions, which should enable continued expansion of services in the US. It needs to carefully manage dependence on third-party data.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q), Investor Presentations, Third-Party Market Research Reports, Analyst Reports
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share data is approximate and based on available industry reports. Financial data may be estimates or based on past performance and is not a guarantee of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Doximity Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2021-06-24 | Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney | ||
Sector Healthcare | Industry Health Information Services | Full time employees 830 | Website https://www.doximity.com |
Full time employees 830 | Website https://www.doximity.com | ||
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.